Clinical Trial: A Study to Evaluate the Effects of an Investigational Drug on the Postprandial (following a meal) Lipoprotein Response in Patients with Primary Hypercholesterolemia (high cholesterol)

This study is currently recruiting patients.

Sponsored by: Merck
Information provided by: Merck

Purpose

A study to evaluate the cholesterol-lowering effects of an investigational drug in patients with primary hypercholesterolemia (high cholesterol) after eating a meal that is high in cholesterol.

Condition Treatment or Intervention Phase
Hypercholesterolemia
 
Phase II
Phase III

MedlinePlus related topics:  Cholesterol

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study

Eligibility

Ages Eligible for Study:  18 Years   -   70 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

  • Eligible patients will be otherwise healthy men and women (if not on oral contraceptives or hormone replacement therapy) 18 through 70 years of age with moderately high cholesterol.

Exclusion Criteria:

  • Individuals on other lipid-lowering therapy (medicines that lower cholesterol) including statins (within 6 weeks) and fibrates (within 8 weeks) prior to administration of the study drug.

Location and Contact Information

Call for Information      1-888-577-8839 

California
      Call for Information, Berkeley,  California,  94705,  United States; Recruiting

More Information

Study ID Numbers:  2005_001
Record last reviewed:  March 2005
Last Updated:  March 18, 2005
Record first received:  January 10, 2005
ClinicalTrials.gov Identifier:  NCT00101439
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources